Dr. John R. Hawse with the Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, talking about his experience publishing "ERβ inhibits cyclin dependent kinases 1 and 7 in triple negative breast cancer" with Oncotarget in 2017.

DOI - https://doi.org/10.18632/oncotarget.21787

Correspondence to - John R. Hawse - [email protected]

Keywords - TNBC, ERβ, cell cycle, CDK, estrogen

About Oncotarget

Oncotarget is a peer-reviewed, open access biomedical journal covering research on all aspects of oncology.

To learn more about Oncotarget, please visit https://www.oncotarget.com or connect with us:

SoundCloud - https://soundcloud.com/oncotarget

Facebook - https://www.facebook.com/Oncotarget/

Twitter - https://twitter.com/oncotarget

Instagram - https://www.instagram.com/oncotargetjrnl/

YouTube - https://www.youtube.com/c/OncotargetYouTube/

LinkedIn - https://www.linkedin.com/company/oncotarget

Pinterest - https://www.pinterest.com/oncotarget/

Reddit - https://www.reddit.com/user/Oncotarget/

Oncotarget is published by Impact Journals, LLC: https://www.ImpactJournals.com

Media Contact

18009220957